All products sold on our website are for research use only. Not intended for human use. You must be 19 years of age or older to place an order.
Free Domestic Shipping on Orders Above $250 Same Day Shipping As Soon As Payment Is Confirmed Independent testing To Meet Quality Standards
Sale!

CJC-1295 No DAC (10 MG)/ Ipamorelin(10 MG)

Original price was: $159.98.Current price is: $109.23.

The CJC-1295 (No DAC) + Ipamorelin Combination Bundle delivers precise, short-acting growth hormone stimulation designed to mimic the body’s natural pulsatile GH release. CJC-1295 (No DAC) initiates GHRH signaling while Ipamorelin triggers clean GH pulses for recovery and metabolic research. Supplied in separate vials to preserve stability, purity, and peptide integrity.

Customers also bought

In stock

Original price was: $49.99.Current price is: $47.49.
Original price was: $64.99.Current price is: $61.74.

In stock

Description

The CJC-1295 (No DAC) + Ipamorelin Combination Bundle is engineered to replicate the body’s natural growth hormone rhythm through a fast-acting, pulsatile GH release system.

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog designed for short-duration activation of the pituitary gland. Without the Drug Affinity Complex, it is rapidly cleared, allowing for tight control of GH timing and preventing prolonged receptor stimulation. This makes it ideal for research into natural GH signaling, lean tissue development, metabolic efficiency, and recovery.

Ipamorelin is a highly selective ghrelin-receptor agonist that triggers clean, physiologic GH pulses without significantly affecting cortisol, prolactin, or other stress hormones. It is widely studied for its role in promoting muscle recovery, fat metabolism, sleep-associated GH release, and tissue repair.

Together, CJC-1295 (No DAC) and Ipamorelin form a synergistic pulsatile GH protocol that supports:

  • Natural growth hormone rhythms

  • Lean mass and recovery signaling

  • Metabolic efficiency

  • Sleep-linked GH release

  • Reduced risk of receptor desensitization

This combination is often preferred in performance and recovery research where tight hormonal control is required.


Why These Peptides Are Supplied in Separate Vials

Although CJC-1295 (No DAC) and Ipamorelin are used together in research protocols, they are never mixed in the same vial.

Each peptide has unique molecular structure, pH sensitivity, and stability requirements. When peptides are combined in solution, they may:

  • Degrade more quickly

  • Lose biological activity

  • Interact chemically in unstable ways

  • Form breakdown products that reduce potency

To ensure maximum purity, accuracy, and pharmaceutical-grade stability, NordisPharma supplies CJC-1295 (No DAC) and Ipamorelin in separate sterile vials. This preserves:

  • Shelf life

  • Concentration accuracy

  • Peptide bioactivity

  • Research consistency

They are designed to be used together as a protocol, but stored separately to protect molecular integrity.

The CJC-1295 (No DAC) + Ipamorelin Combination Bundle is engineered to replicate the body’s natural growth hormone rhythm through a fast-acting, pulsatile GH release system.

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog designed for short-duration activation of the pituitary gland. Without the Drug Affinity Complex, it is rapidly cleared, allowing for tight control of GH timing and preventing prolonged receptor stimulation. This makes it ideal for research into natural GH signaling, lean tissue development, metabolic efficiency, and recovery.

Ipamorelin is a highly selective ghrelin-receptor agonist that triggers clean, physiologic GH pulses without significantly affecting cortisol, prolactin, or other stress hormones. It is widely studied for its role in promoting muscle recovery, fat metabolism, sleep-associated GH release, and tissue repair.

Together, CJC-1295 (No DAC) and Ipamorelin form a synergistic pulsatile GH protocol that supports:

  • Natural growth hormone rhythms

  • Lean mass and recovery signaling

  • Metabolic efficiency

  • Sleep-linked GH release

  • Reduced risk of receptor desensitization

This combination is often preferred in performance and recovery research where tight hormonal control is required.


Why These Peptides Are Supplied in Separate Vials

Although CJC-1295 (No DAC) and Ipamorelin are used together in research protocols, they are never mixed in the same vial.

Each peptide has unique molecular structure, pH sensitivity, and stability requirements. When peptides are combined in solution, they may:

  • Degrade more quickly

  • Lose biological activity

  • Interact chemically in unstable ways

  • Form breakdown products that reduce potency

To ensure maximum purity, accuracy, and pharmaceutical-grade stability, NordisPharma supplies CJC-1295 (No DAC) and Ipamorelin in separate sterile vials. This preserves:

  • Shelf life

  • Concentration accuracy

  • Peptide bioactivity

  • Research consistency

They are designed to be used together as a protocol, but stored separately to protect molecular integrity.

The CJC-1295 (No DAC) + Ipamorelin Combination Bundle is engineered to replicate the body’s natural growth hormone rhythm through a fast-acting, pulsatile GH release system.

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog designed for short-duration activation of the pituitary gland. Without the Drug Affinity Complex, it is rapidly cleared, allowing for tight control of GH timing and preventing prolonged receptor stimulation. This makes it ideal for research into natural GH signaling, lean tissue development, metabolic efficiency, and recovery.

Ipamorelin is a highly selective ghrelin-receptor agonist that triggers clean, physiologic GH pulses without significantly affecting cortisol, prolactin, or other stress hormones. It is widely studied for its role in promoting muscle recovery, fat metabolism, sleep-associated GH release, and tissue repair.

Together, CJC-1295 (No DAC) and Ipamorelin form a synergistic pulsatile GH protocol that supports:

  • Natural growth hormone rhythms

  • Lean mass and recovery signaling

  • Metabolic efficiency

  • Sleep-linked GH release

  • Reduced risk of receptor desensitization

This combination is often preferred in performance and recovery research where tight hormonal control is required.


Why These Peptides Are Supplied in Separate Vials

Although CJC-1295 (No DAC) and Ipamorelin are used together in research protocols, they are never mixed in the same vial.

Each peptide has unique molecular structure, pH sensitivity, and stability requirements. When peptides are combined in solution, they may:

  • Degrade more quickly

  • Lose biological activity

  • Interact chemically in unstable ways

  • Form breakdown products that reduce potency

To ensure maximum purity, accuracy, and pharmaceutical-grade stability, NordisPharma supplies CJC-1295 (No DAC) and Ipamorelin in separate sterile vials. This preserves:

  • Shelf life

  • Concentration accuracy

  • Peptide bioactivity

  • Research consistency

They are designed to be used together as a protocol, but stored separately to protect molecular integrity.